Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Atirmociclib in Hepatic Impairment
NCT07677358Phase 1Recruiting
- Sponsor
- Pfizer
- Start
- Jun 2026
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Phase 1, open-label trial of atirmociclib (4 arms), sponsored by Pfizer. Primary endpoints: Maximum Observed Plasma Concentration up to 192 hours and Area under the curve from time zero to extrapolated infinite time up to 192 hours. Started Jun 2026; status: recruiting.
02
Drugs
atirmociclib
Beyond the preview
Go deeper on NCT07677358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07677358.